MeSH term
Frequency | Condition_Probility | Female | 321 | 0.0 |
Humans | 760 | 0.0 |
Pregnancy | 27 | 0.0 |
Pregnancy Outcome | 2 | 0.0 |
Adolescent | 108 | 0.0 |
Male | 279 | 0.0 |
Tomography, X-Ray Computed | 3 | 0.0 |
Adult | 239 | 0.0 |
Data Collection | 2 | 2.0 |
Sex Factors | 5 | 0.0 |
Animals | 205 | 0.0 |
Carcinoma, Papillary/epidemiology/*genetics | 2 | 22.0 |
*Drosophila Proteins | 2 | 0.0 |
*Gene Rearrangement | 3 | 1.0 |
Oncogene Proteins, Fusion/genetics | 2 | 2.0 |
Proto-Oncogene Proteins/*genetics | 7 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 138 | 0.0 |
Thyroid Neoplasms/epidemiology/*genetics | 2 | 22.0 |
Aged | 123 | 0.0 |
Chronic Disease | 14 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 59 | 1.0 |
Gene Expression | 21 | 0.0 |
Middle Aged | 191 | 0.0 |
RNA, Messenger/*metabolism | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 21 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Infant, Newborn | 38 | 0.0 |
Platelet Count | 98 | 20.0 |
Purpura, Thrombocytopenic, Idiopathic/*blood | 7 | 63.0 |
Thrombopoietin/*blood | 96 | 97.0 |
Amino Acid Sequence | 70 | 0.0 |
Autoantibodies/*genetics/immunology | 2 | 33.0 |
Epitopes/immunology | 10 | 1.0 |
Genes, Immunoglobulin | 4 | 2.0 |
Immunoglobulins, Heavy-Chain/genetics | 5 | 3.0 |
Immunoglobulins, Light-Chain/genetics | 4 | 11.0 |
Iodide Peroxidase/*immunology | 68 | 90.0 |
Molecular Sequence Data | 94 | 0.0 |
Sequence Alignment | 7 | 0.0 |
Thyroiditis, Autoimmune/genetics/*immunology | 3 | 42.0 |
Clinical Trials | 4 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use | 2 | 7.0 |
*Hematopoietic Stem Cell Mobilization | 4 | 6.0 |
*Hematopoietic Stem Cell Transplantation | 9 | 2.0 |
Cytokines/*therapeutic use | 2 | 11.0 |
Dose-Response Relationship, Drug | 16 | 0.0 |
Neoplasms/therapy | 2 | 4.0 |
Platelet Transfusion | 9 | 30.0 |
Thrombocytopenia/chemically induced/drug therapy | 2 | 100.0 |
Thrombopoiesis/drug effects | 3 | 100.0 |
Cell Count | 9 | 0.0 |
Chemiluminescent Measurements | 3 | 1.0 |
Hematopoiesis | 13 | 5.0 |
Immunoassay | 4 | 1.0 |
Immunoenzyme Techniques | 10 | 0.0 |
Immunohistochemistry | 27 | 0.0 |
Myelofibrosis/*metabolism | 2 | 100.0 |
*Neoplasm Proteins | 69 | 9.0 |
Proto-Oncogene Proteins/*analysis | 3 | 1.0 |
*Receptors, Cytokine | 63 | 46.0 |
Spleen/pathology | 8 | 11.0 |
Diet | 4 | 1.0 |
Rats | 25 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 25 | 0.0 |
Risk Assessment | 2 | 0.0 |
Thyroid Gland/drug effects/physiology | 2 | 100.0 |
Acute Disease | 7 | 0.0 |
Aged, 80 and over | 45 | 0.0 |
Myeloproliferative Disorders/*chemically induced/pathology | 2 | 100.0 |
Retrospective Studies | 8 | 0.0 |
Thrombopoietin/*adverse effects | 2 | 100.0 |
African Americans | 2 | 1.0 |
Cohort Studies | 6 | 0.0 |
Comparative Study | 91 | 0.0 |
Health Services Research | 2 | 11.0 |
Research Support, Non-U.S. Gov't | 371 | 0.0 |
Risk Factors | 8 | 0.0 |
Child | 59 | 0.0 |
DNA/analysis | 6 | 0.0 |
Infant | 36 | 0.0 |
Polymerase Chain Reaction | 30 | 0.0 |
Proto-Oncogene Proteins/*genetics/*physiology | 2 | 20.0 |
Bone Marrow Cells/cytology | 4 | 5.0 |
Cell Survival/drug effects | 4 | 0.0 |
Drug Synergism | 9 | 0.0 |
Fetal Blood/cytology | 4 | 2.0 |
Hematopoietic Stem Cells/*cytology/drug effects | 7 | 10.0 |
Myeloid Progenitor Cells/cytology/drug effects | 2 | 33.0 |
Tumor Cells, Cultured | 23 | 0.0 |
Reference Values | 21 | 0.0 |
Solubility | 10 | 0.0 |
Statistics, Nonparametric | 8 | 0.0 |
Base Sequence | 53 | 0.0 |
Cell Line | 39 | 0.0 |
Gene Library | 9 | 0.0 |
Megakaryocytes/metabolism | 5 | 12.0 |
Mice | 88 | 0.0 |
Molecular Weight | 9 | 0.0 |
Spleen/metabolism | 3 | 2.0 |
Transfection | 28 | 0.0 |
Biological Markers/blood | 18 | 1.0 |
Child, Preschool | 41 | 0.0 |
Megakaryocytes/*pathology | 9 | 31.0 |
Mutation | 12 | 0.0 |
Platelet Glycoprotein GPIb-IX Complex/*analysis | 4 | 80.0 |
Proto-Oncogene Proteins/genetics | 4 | 0.0 |
Thrombocytopenia/blood/*congenital/pathology | 2 | 100.0 |
Thrombopoietin/*metabolism | 19 | 70.0 |
Gestational Age | 4 | 0.0 |
Infant, Premature/*blood | 3 | 9.0 |
Sepsis/blood | 2 | 18.0 |
Kidney/metabolism | 3 | 0.0 |
Platelet Glycoprotein GPIb-IX Complex/metabolism | 2 | 3.0 |
Renal Dialysis | 2 | 0.0 |
Flow Cytometry | 28 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Recombinant Proteins/pharmacology | 21 | 1.0 |
Thrombopoietin/*pharmacology | 35 | 36.0 |
CHO Cells | 22 | 1.0 |
Circular Dichroism | 2 | 0.0 |
DNA Primers | 10 | 0.0 |
Epitope Mapping | 7 | 2.0 |
Hamsters | 26 | 0.0 |
Models, Immunological | 2 | 0.0 |
Models, Molecular | 10 | 0.0 |
Mutagenesis, Site-Directed | 8 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Iodides/metabolism | 5 | 45.0 |
Tissue Distribution | 4 | 0.0 |
Autoantibodies/analysis | 11 | 6.0 |
Protirelin/diagnostic use | 2 | 1.0 |
Thyroid Function Tests | 13 | 15.0 |
Thyroid Hormones/blood | 6 | 6.0 |
Thyrotropin/metabolism | 4 | 7.0 |
Age of Onset | 2 | 0.0 |
English Abstract | 59 | 0.0 |
Family | 2 | 0.0 |
Glutamate Decarboxylase/immunology | 2 | 6.0 |
Insulin/immunology | 2 | 15.0 |
Iodide Peroxidase/immunology | 36 | 65.0 |
China | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
Heterozygote | 4 | 0.0 |
Hypothyroidism/*genetics | 2 | 18.0 |
Iodide Peroxidase/*genetics | 27 | 65.0 |
Iodides/*metabolism | 13 | 81.0 |
Mutation, Missense | 3 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Blood Platelets/*metabolism | 13 | 4.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Phosphorylation | 13 | 0.0 |
Platelet Aggregation | 2 | 1.0 |
Proteins/metabolism | 2 | 0.0 |
Thrombin/pharmacology | 2 | 0.0 |
Thrombopoietin/pharmacology | 13 | 25.0 |
Hematopoiesis/*physiology | 11 | 12.0 |
Proto-Oncogene Proteins/*physiology | 7 | 3.0 |
Thrombopoietin/*physiology | 13 | 68.0 |
Amino Acid Substitution | 2 | 0.0 |
DNA Mutational Analysis | 8 | 0.0 |
Exons/genetics | 4 | 0.0 |
Gene Frequency | 7 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Thrombocythemia, Hemorrhagic/*genetics | 2 | 66.0 |
Thrombopoietin/blood/*genetics | 4 | 100.0 |
Autoantibodies/*analysis | 21 | 9.0 |
Chromatography, Affinity/methods | 2 | 2.0 |
Iodide Peroxidase/*analysis/immunology | 3 | 100.0 |
Iodine Radioisotopes | 3 | 0.0 |
Thyroid Gland/enzymology | 13 | 61.0 |
C-Reactive Protein/metabolism | 4 | 1.0 |
Interleukin-6/blood | 12 | 2.0 |
Longitudinal Studies | 3 | 0.0 |
Combinatorial Chemistry Techniques | 2 | 10.0 |
Immunoglobulin Variable Region/genetics | 3 | 2.0 |
Recombinant Proteins/immunology | 8 | 2.0 |
Thyroiditis, Autoimmune/etiology/*immunology | 3 | 60.0 |
Antigens, CD34 | 6 | 0.0 |
Cell Division/drug effects | 28 | 0.0 |
Genetic Vectors | 10 | 0.0 |
Hematopoietic Stem Cell Mobilization | 5 | 5.0 |
Thrombopoietin/genetics/pharmacology | 2 | 100.0 |
Umbilical Veins | 2 | 0.0 |
Blood Platelets/*physiology | 10 | 5.0 |
Glucocorticoids/therapeutic use | 2 | 2.0 |
Immunoglobulins, Intravenous/therapeutic use | 3 | 8.0 |
Splenectomy | 2 | 3.0 |
Thrombopoietin/*analysis | 7 | 100.0 |
Fetal Blood/*chemistry | 3 | 5.0 |
Infant, Low Birth Weight | 2 | 7.0 |
Infant, Premature | 4 | 3.0 |
Infant, Premature, Diseases/*blood | 3 | 42.0 |
Interleukin-11/blood | 8 | 61.0 |
Thrombocytosis/*blood | 10 | 83.0 |
Adenoviridae/*genetics | 2 | 0.0 |
Biological Transport | 4 | 0.0 |
Iodide Peroxidase/*genetics/metabolism | 3 | 60.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Recombinant Proteins | 9 | 1.0 |
Thyroid Gland/*metabolism | 5 | 12.0 |
Molecular Biology | 2 | 0.0 |
*Apoptosis | 2 | 0.0 |
Cell Division | 28 | 0.0 |
Cell Lineage | 3 | 0.0 |
Cells, Cultured | 61 | 0.0 |
Culture Media, Serum-Free/pharmacology | 3 | 2.0 |
Fetal Blood/*metabolism | 2 | 4.0 |
Interleukin-3/biosynthesis | 2 | 22.0 |
Microscopy, Electron | 7 | 0.0 |
Ploidies | 6 | 2.0 |
Time Factors | 32 | 0.0 |
Liver/*metabolism | 3 | 0.0 |
Neoplasm Proteins/metabolism | 4 | 1.0 |
RNA, Messenger/genetics | 7 | 0.0 |
Follow-Up Studies | 11 | 0.0 |
Forecasting | 4 | 1.0 |
Thyroglobulin/immunology | 22 | 40.0 |
Anemia, Aplastic/*blood | 6 | 50.0 |
Purpura, Thrombocytopenic, Idiopathic/*blood/drug therapy | 2 | 100.0 |
Antigens, CD34/analysis | 14 | 2.0 |
Culture Media, Conditioned | 5 | 1.0 |
Interleukin-11/pharmacology | 3 | 12.0 |
Interleukin-3/pharmacology | 13 | 4.0 |
Interleukin-6/pharmacology | 8 | 2.0 |
RNA, Messenger/analysis | 16 | 0.0 |
Stem Cell Factor/pharmacology | 8 | 5.0 |
Predictive Value of Tests | 8 | 0.0 |
Hematopoietic Stem Cells/*metabolism | 3 | 2.0 |
P-Selectin/blood | 2 | 3.0 |
Platelet-Derived Growth Factor/metabolism | 2 | 3.0 |
Transplantation, Autologous | 8 | 2.0 |
Antigens, CD34/blood | 3 | 5.0 |
Cell Culture Techniques/methods | 6 | 2.0 |
Cell Differentiation/drug effects | 12 | 1.0 |
Drug Interactions | 2 | 0.0 |
Growth Substances/pharmacology | 2 | 1.0 |
Hematologic Neoplasms/therapy | 2 | 8.0 |
Immunophenotyping | 8 | 0.0 |
Lymphocyte Culture Test, Mixed | 2 | 0.0 |
Antibodies/*blood | 4 | 8.0 |
Cyclosporine/therapeutic use | 2 | 2.0 |
Immunoglobulin G/blood | 9 | 3.0 |
Immunosuppressive Agents/therapeutic use | 2 | 0.0 |
Kinetics | 25 | 0.0 |
Megakaryocytes/pathology | 9 | 50.0 |
Proto-Oncogene Proteins/metabolism | 9 | 0.0 |
Antibodies, Monoclonal | 14 | 0.0 |
Cattle | 5 | 0.0 |
Enzyme-Linked Immunosorbent Assay/methods | 6 | 2.0 |
Receptors, Thyrotropin/immunology | 7 | 38.0 |
Swine | 16 | 1.0 |
Thyroid Gland/*immunology | 21 | 34.0 |
Blood Cell Count | 4 | 1.0 |
Megakaryocytes/*cytology | 16 | 30.0 |
Thrombopoietin/blood | 11 | 84.0 |
Cell Culture Techniques | 3 | 0.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Interleukin-6/*blood | 9 | 3.0 |
Severity of Illness Index | 4 | 0.0 |
Thrombocytosis/*blood/*diagnosis | 2 | 100.0 |
Antineoplastic Agents/adverse effects | 4 | 13.0 |
Blood Platelets/*cytology | 6 | 25.0 |
Hematopoiesis/*drug effects | 8 | 8.0 |
Mice, Inbred C57BL | 15 | 0.0 |
RNA, Messenger/drug effects/metabolism | 3 | 2.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
In Vitro | 20 | 0.0 |
Megakaryocytes/cytology/*physiology | 3 | 42.0 |
Recombinant Proteins/metabolism | 9 | 0.0 |
Iodide Peroxidase/*biosynthesis | 2 | 100.0 |
Thyroiditis, Autoimmune/immunology | 15 | 44.0 |
Iodide Peroxidase/blood/*immunology | 4 | 80.0 |
Antigens, CD34/*metabolism | 3 | 2.0 |
Fetal Blood/*cytology | 10 | 5.0 |
Megakaryocytes/*cytology/metabolism | 2 | 66.0 |
Blotting, Western | 25 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 21 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Graves' Disease/*enzymology | 4 | 80.0 |
Iodide Peroxidase/*metabolism | 19 | 79.0 |
Microsomes/enzymology/immunology | 5 | 100.0 |
Thyroid Diseases/*enzymology | 4 | 80.0 |
Thyroid Gland/*enzymology | 14 | 70.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Bone Marrow Cells/metabolism | 4 | 4.0 |
DNA-Binding Proteins/metabolism | 7 | 0.0 |
Genotype | 6 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Mice, Inbred BALB C | 19 | 0.0 |
Mitosis | 3 | 0.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Proteins/*physiology | 2 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 11 | 1.0 |
Retroviridae/genetics | 3 | 0.0 |
*Signal Transduction | 4 | 0.0 |
Spleen/cytology | 2 | 1.0 |
Trans-Activators/metabolism | 7 | 0.0 |
Colony-Stimulating Factors/*pharmacology | 2 | 4.0 |
Erythropoiesis/*drug effects | 5 | 10.0 |
Erythropoietin/pharmacology | 5 | 3.0 |
Granulocyte Colony-Stimulating Factor/pharmacology | 6 | 3.0 |
Leukocytes, Mononuclear/cytology | 2 | 4.0 |
Leukopoiesis/*drug effects | 2 | 66.0 |
Prospective Studies | 12 | 0.0 |
Thrombocytopenia/*blood/complications | 2 | 50.0 |
Blood Platelets/drug effects/pathology | 2 | 100.0 |
Gene Expression Regulation | 7 | 0.0 |
Hematopoietic Stem Cells/drug effects | 2 | 3.0 |
Mice, Knockout | 5 | 0.0 |
*Mutation | 13 | 0.0 |
Pancytopenia/etiology | 2 | 33.0 |
*Chromosome Mapping | 4 | 0.0 |
DNA, Recombinant | 5 | 2.0 |
Mutation/genetics | 3 | 0.0 |
Variation (Genetics) | 3 | 0.0 |
Cell Culture Techniques/*methods | 2 | 2.0 |
Cytokines/pharmacology | 5 | 1.0 |
Membrane Proteins/pharmacology | 4 | 9.0 |
Mice, Inbred NOD | 5 | 2.0 |
Mice, SCID | 9 | 1.0 |
Phenotype | 7 | 0.0 |
Blood Platelets/*pathology | 2 | 13.0 |
Diagnosis, Differential | 9 | 0.0 |
Thrombocytopenia/blood/*diagnosis/etiology | 2 | 100.0 |
Biopsy, Needle | 7 | 1.0 |
Sensitivity and Specificity | 19 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Alleles | 5 | 0.0 |
Family Health | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
Iodine/*metabolism | 6 | 42.0 |
Mutagenesis | 4 | 0.0 |
Sequence Deletion | 5 | 0.0 |
Liver/enzymology | 2 | 0.0 |
Radioimmunoassay | 12 | 0.0 |
Thyrotropin/blood | 29 | 7.0 |
Thyroxine/blood | 15 | 5.0 |
Triiodothyronine/blood | 11 | 5.0 |
Case-Control Studies | 19 | 0.0 |
Cytokines/metabolism | 3 | 0.0 |
Thyroiditis, Autoimmune/*immunology | 26 | 33.0 |
Hormone Replacement Therapy | 2 | 5.0 |
Thrombocytosis | 2 | 66.0 |
Arthroplasty, Replacement, Hip | 2 | 22.0 |
Blood Platelets/chemistry | 3 | 10.0 |
Interleukin-6/*analysis/pharmacology | 2 | 100.0 |
Postoperative Complications/*blood | 2 | 9.0 |
Thrombopoietin/analysis/*blood | 2 | 100.0 |
Proto-Oncogene Proteins/blood | 3 | 37.0 |
Antigens, CD/blood | 3 | 1.0 |
Integrin beta3 | 2 | 4.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/analysis | 5 | 20.0 |
Platelet-Derived Growth Factor/*pharmacology | 2 | 2.0 |
Biological Markers | 11 | 0.0 |
Cell Differentiation/physiology | 4 | 0.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
Megakaryocytes/*cytology/*physiology | 2 | 66.0 |
Receptors, Cytokine/physiology | 2 | 7.0 |
Transcription Factors/physiology | 2 | 0.0 |
Autoantibodies/*blood | 24 | 8.0 |
Incidence | 3 | 0.0 |
Epitopes/chemistry | 2 | 2.0 |
Iodide Peroxidase/chemistry/*immunology | 10 | 90.0 |
Reference Standards | 2 | 0.0 |
*Blood Platelets | 3 | 14.0 |
Hemoglobins/analysis | 5 | 1.0 |
Leukocyte Count | 11 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Iodide Peroxidase/chemistry/*genetics | 2 | 100.0 |
Pedigree | 19 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Thyroglobulin/blood | 4 | 6.0 |
Blotting, Northern | 17 | 0.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/*analysis | 2 | 66.0 |
Iodides/pharmacology | 2 | 25.0 |
Enzyme Activation | 6 | 0.0 |
Octoxynol | 2 | 3.0 |
Protein Transport | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 5 | 0.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Erythropoietin/*blood | 6 | 2.0 |
Thrombocythemia, Hemorrhagic/*blood | 6 | 60.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Erythroid Progenitor Cells/*drug effects | 2 | 15.0 |
Megakaryocytes/*drug effects | 2 | 28.0 |
*Milk Proteins | 7 | 1.0 |
*Proto-Oncogene Proteins | 8 | 0.0 |
Blood Platelets/drug effects | 5 | 19.0 |
Megakaryocytes/drug effects | 2 | 66.0 |
Antibodies, Monoclonal/*immunology | 7 | 0.0 |
Antibody Affinity | 6 | 3.0 |
Antibody Specificity | 23 | 1.0 |
Autoantibodies/*immunology | 30 | 12.0 |
Immunoglobulins, Fab/immunology | 7 | 6.0 |
Gene Frequency/*genetics | 2 | 1.0 |
Minisatellite Repeats/*genetics | 3 | 4.0 |
Mozambique | 2 | 25.0 |
Blood Platelets/cytology/*physiology | 2 | 18.0 |
Antibodies/blood | 4 | 6.0 |
Autoantibodies/blood | 15 | 8.0 |
Graves' Disease/*enzymology/immunology | 2 | 100.0 |
RNA, Messenger/biosynthesis | 6 | 0.0 |
Thyroid Hormones/*biosynthesis | 3 | 42.0 |
Antibodies, Monoclonal/immunology | 17 | 1.0 |
Epitopes/*chemistry/immunology | 2 | 22.0 |
Immunosorbent Techniques | 5 | 1.0 |
Iodide Peroxidase/*chemistry/*immunology | 6 | 100.0 |
Peptide Fragments/*immunology | 2 | 1.0 |
Protein Conformation | 13 | 0.0 |
Antigen Presentation | 3 | 0.0 |
Carbohydrates/analysis | 2 | 3.0 |
Iodide Peroxidase/chemistry/immunology | 2 | 100.0 |
Protein Binding | 9 | 0.0 |
T-Lymphocytes/*immunology | 8 | 0.0 |
Thyroid Hormones/*immunology | 2 | 66.0 |
Chi-Square Distribution | 3 | 0.0 |
Hematologic Tests | 2 | 5.0 |
Neoplasm Proteins/*genetics | 3 | 0.0 |
*Platelet Count | 13 | 39.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Receptors, Cytokine/*genetics | 3 | 5.0 |
Thrombopoietin/*genetics | 9 | 100.0 |
Nitric-Oxide Synthase/metabolism | 2 | 1.0 |
*Platelet Transfusion | 2 | 8.0 |
*Hematopoiesis | 11 | 5.0 |
Hematopoietic Stem Cells/cytology | 5 | 5.0 |
RNA, Messenger/metabolism | 15 | 0.0 |
Stromal Cells/cytology | 3 | 6.0 |
*Gene Expression | 7 | 0.0 |
Goiter/*metabolism/pathology | 2 | 66.0 |
Thyroid Hormones/*blood | 3 | 5.0 |
Proto-Oncogene Proteins/*biosynthesis/genetics | 2 | 2.0 |
RNA, Messenger/biosynthesis/genetics | 4 | 0.0 |
Thrombopoietin/biosynthesis/*genetics | 2 | 100.0 |
Cross-Sectional Studies | 4 | 0.0 |
Liver Cirrhosis/blood/complications | 2 | 20.0 |
*Chromosomes, Human, Pair 2 | 3 | 1.0 |
Gene Deletion | 3 | 0.0 |
Genetic Markers | 6 | 0.0 |
Homozygote | 2 | 0.0 |
Thyroxine/blood/therapeutic use | 3 | 20.0 |
Disease Models, Animal | 4 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Cell Differentiation | 12 | 0.0 |
Combined Modality Therapy | 3 | 0.0 |
*Enzyme Tests | 3 | 4.0 |
False Negative Reactions | 2 | 1.0 |
Iodide Peroxidase/*blood | 8 | 88.0 |
Postoperative Period | 3 | 0.0 |
Thyroglobulin/*blood | 3 | 1.0 |
Thyroidectomy | 9 | 6.0 |
Tumor Markers, Biological/*blood | 4 | 0.0 |
Signal Transduction/drug effects | 5 | 0.0 |
Autoimmunity/immunology | 2 | 6.0 |
Germany/epidemiology | 2 | 1.0 |
Immunoglobulin A/blood | 2 | 1.0 |
Transglutaminases/immunology | 2 | 28.0 |
Blood Transfusion | 2 | 1.0 |
*Liver Transplantation | 5 | 3.0 |
Neutrophils/cytology | 2 | 4.0 |
Platelet Glycoprotein GPIb-IX Complex/analysis | 5 | 29.0 |
Pregnancy Trimester, Second | 2 | 0.0 |
DNA, Complementary/genetics | 6 | 0.0 |
Introns/*genetics | 2 | 1.0 |
RNA Splicing/*genetics | 2 | 2.0 |
Substrate Specificity | 4 | 0.0 |
Erythropoietin/blood/therapeutic use | 2 | 66.0 |
Hematocrit | 2 | 0.0 |
Recombinant Proteins/therapeutic use | 3 | 0.0 |
Renal Dialysis/*adverse effects | 3 | 2.0 |
Thrombocytopenia/*etiology | 5 | 31.0 |
Blood Platelets/*drug effects | 3 | 7.0 |
Colony-Forming Units Assay | 15 | 2.0 |
Cytokines/blood | 3 | 1.0 |
Megakaryocytes/cytology/drug effects | 7 | 53.0 |
*Peptide Library | 2 | 3.0 |
Blood Donors | 2 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Platelet Activation/*drug effects | 3 | 4.0 |
Recombinant Proteins/administration & dosage | 3 | 3.0 |
Biotinylation | 2 | 1.0 |
Recombinant Proteins/chemistry/immunology | 3 | 10.0 |
Trypsin/metabolism | 2 | 1.0 |
Adenosine Diphosphate/pharmacology | 2 | 1.0 |
Disease Progression | 3 | 0.0 |
Platelet Activation/drug effects | 2 | 3.0 |
Prognosis | 5 | 0.0 |
Signal Transduction | 7 | 0.0 |
Autoantigens/chemistry/*immunology | 3 | 42.0 |
B-Lymphocytes/immunology | 5 | 0.0 |
Immunoglobulin Isotypes/immunology | 2 | 6.0 |
Immunoglobulin Variable Region/immunology | 3 | 10.0 |
T-Lymphocytes/immunology | 5 | 0.0 |
Thyroid Gland/immunology | 10 | 23.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 3 | 0.0 |
Regression Analysis | 5 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Coculture Techniques | 2 | 0.0 |
Interleukin-3/metabolism | 5 | 17.0 |
Linear Models | 2 | 0.0 |
Receptors, Cytokine/metabolism | 4 | 4.0 |
Thrombopoietin/metabolism | 7 | 58.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
*DNA Fingerprinting | 2 | 4.0 |
Software | 2 | 0.0 |
Tandem Repeat Sequences/*genetics | 3 | 3.0 |
Blood Platelets/physiology | 5 | 8.0 |
Crosses, Genetic | 3 | 0.0 |
Iodide Peroxidase/genetics | 5 | 45.0 |
Mice, Transgenic | 6 | 0.0 |
Promoter Regions (Genetics)/genetics | 5 | 0.0 |
Blood Platelets/metabolism | 4 | 2.0 |
Cricetulus | 4 | 0.0 |
Point Mutation/*genetics | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
Receptors, Thyrotropin/*immunology | 6 | 16.0 |
Thyroglobulin/*immunology | 15 | 16.0 |
Lymphocyte Activation | 7 | 0.0 |
Mice, Inbred AKR | 3 | 6.0 |
Cell Separation | 6 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 7 | 1.0 |
Transplantation, Heterologous | 5 | 0.0 |
Iodide Peroxidase/*analysis | 14 | 100.0 |
Thyroglobulin/*analysis | 4 | 18.0 |
Thyrotropin/*blood | 2 | 1.0 |
Iodide Peroxidase/*antagonists & inhibitors | 5 | 83.0 |
Hematopoiesis/drug effects | 6 | 7.0 |
Thrombocytopenia/drug therapy/etiology | 2 | 50.0 |
Thrombopoietin/*therapeutic use | 2 | 100.0 |
Cell Differentiation/drug effects/immunology | 2 | 2.0 |
Cell Division/drug effects/immunology | 2 | 3.0 |
Culture Media, Serum-Free | 8 | 2.0 |
Cytokines/*pharmacology | 7 | 1.0 |
Megakaryocytes/cytology | 7 | 29.0 |
Thrombocytopenia/*genetics | 3 | 23.0 |
Hydrogen-Ion Concentration | 6 | 0.0 |
Polyethylene Glycols/pharmacology | 2 | 4.0 |
Guaiacol/metabolism | 8 | 100.0 |
Oxidation-Reduction | 8 | 0.0 |
Recombinant Proteins/immunology/metabolism | 2 | 4.0 |
Spectrophotometry | 2 | 1.0 |
Spectrophotometry, Ultraviolet | 3 | 1.0 |
Thyroid Diseases/immunology | 2 | 15.0 |
Granulocyte Colony-Stimulating Factor/*pharmacology | 2 | 1.0 |
Analysis of Variance | 10 | 0.0 |
Blood Platelets/pathology | 3 | 16.0 |
Platelet Count/*drug effects | 3 | 42.0 |
Fibrinogen/metabolism | 4 | 1.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Iodide Peroxidase/immunology/metabolism | 3 | 100.0 |
Thyroiditis, Autoimmune/etiology | 2 | 66.0 |
Binding Sites | 5 | 0.0 |
Pregnancy Complications | 2 | 7.0 |
Tumor Markers, Biological/*analysis | 4 | 0.0 |
Iodine Radioisotopes/therapeutic use | 2 | 5.0 |
Questionnaires | 3 | 0.0 |
Thyroxine/therapeutic use | 2 | 5.0 |
Linkage (Genetics) | 10 | 0.0 |
Thrombocytosis/*genetics | 2 | 66.0 |
Dogs | 5 | 0.0 |
Fluorescent Antibody Technique | 10 | 0.0 |
Organ Specificity | 4 | 0.0 |
Species Specificity | 5 | 0.0 |
Introns | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Hematopoiesis/physiology | 4 | 9.0 |
Recombinant Proteins/chemistry | 3 | 0.0 |
Thrombopoietin/*drug effects | 2 | 100.0 |
Hela Cells | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
DNA/isolation & purification | 2 | 1.0 |
Reproducibility of Results | 9 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Thrombopoietin/*biosynthesis/genetics | 2 | 100.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
Fetal Blood/chemistry | 3 | 5.0 |
Thrombocytopenia/*blood | 9 | 64.0 |
Binding Sites, Antibody | 5 | 1.0 |
Immune Sera/immunology | 5 | 2.0 |
Molecular Structure | 6 | 0.0 |
Peptide Mapping | 5 | 1.0 |
Rabbits | 10 | 0.0 |
Peroxidase/*genetics | 2 | 3.0 |
Feedback | 2 | 1.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Thrombocytopenia/blood | 5 | 50.0 |
Up-Regulation | 3 | 0.0 |
Brazil | 2 | 0.0 |
Hypothyroidism/*immunology | 5 | 50.0 |
X Chromosome | 2 | 0.0 |
Blood Platelets/cytology | 3 | 12.0 |
Megakaryocytes/drug effects/physiology | 2 | 66.0 |
Antithyroid Agents/*pharmacology | 2 | 33.0 |
Enzyme Inhibitors/*pharmacology | 3 | 0.0 |
Heat | 4 | 0.0 |
Hydrogen Peroxide/metabolism | 4 | 3.0 |
Iodides/chemistry | 2 | 33.0 |
Methimazole/pharmacology | 5 | 38.0 |
Propylthiouracil/pharmacology | 4 | 33.0 |
Administration, Oral | 2 | 0.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Membrane Proteins/*genetics | 3 | 0.0 |
Receptors, Thyrotropin/genetics | 8 | 32.0 |
*Symporters | 7 | 7.0 |
Thyroglobulin/genetics | 4 | 21.0 |
Thyroid Neoplasms/*metabolism | 2 | 5.0 |
Immunoassay/methods | 2 | 3.0 |
Bone Marrow Transplantation/*physiology | 2 | 22.0 |
Breast Neoplasms/therapy | 2 | 13.0 |
Leukemia/therapy | 2 | 5.0 |
Transplantation, Homologous | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Thrombopoietin/physiology | 2 | 50.0 |
Dimerization | 3 | 0.0 |
Goiter/enzymology | 2 | 50.0 |
Iodide Peroxidase/*antagonists & inhibitors/metabolism | 3 | 100.0 |
Antibodies/analysis | 3 | 2.0 |
Graves' Disease/*immunology | 21 | 24.0 |
Adenoma/*enzymology | 2 | 33.0 |
In Situ Hybridization | 3 | 0.0 |
Iodide Peroxidase/genetics/*metabolism | 2 | 66.0 |
Thyroid Neoplasms/*enzymology | 5 | 50.0 |
Platelet Count/drug effects | 4 | 11.0 |
Survival Rate | 2 | 0.0 |
Bone Marrow Cells/*metabolism | 2 | 4.0 |
Hematologic Diseases/*blood/therapy | 2 | 100.0 |
Prolactin/blood | 3 | 0.0 |
Stimulation, Chemical | 5 | 1.0 |
Thyroid Gland/physiopathology | 2 | 10.0 |
Thyroxine/*blood | 2 | 5.0 |
Evaluation Studies | 5 | 0.0 |
Hemagglutination Tests | 5 | 5.0 |
Reagent Kits, Diagnostic | 2 | 1.0 |
Antigens, CD34/*blood | 2 | 2.0 |
Culture Media | 3 | 0.0 |
Treatment Outcome | 4 | 0.0 |
Immunoblotting | 6 | 0.0 |
Bone Marrow/pathology | 7 | 1.0 |
Platelet Activation | 2 | 1.0 |
Cell Lineage/drug effects | 2 | 18.0 |
Autoimmunity | 5 | 3.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
Iodine/administration & dosage | 3 | 60.0 |
Thyroid Gland/enzymology/immunology | 6 | 100.0 |
Age Factors | 7 | 0.0 |
Islets of Langerhans/immunology | 2 | 5.0 |
Isoenzymes/*immunology | 2 | 15.0 |
Liver Function Tests | 6 | 3.0 |
Cell Size | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Chromosomes, Human, Pair 21 | 2 | 1.0 |
*Genes, Dominant | 3 | 1.0 |
Blood Sedimentation | 2 | 1.0 |
Iodide Peroxidase/metabolism | 5 | 41.0 |
Blood Platelets/immunology | 3 | 4.0 |
Hepatitis/complications | 2 | 22.0 |
Kidney Failure, Chronic/therapy | 2 | 5.0 |
Thrombocytopenia/blood/*etiology | 3 | 60.0 |
Fetal Blood | 3 | 2.0 |
Antineoplastic Combined Chemotherapy Protocols/*adverse effects | 3 | 6.0 |
*HIV-1 | 2 | 0.0 |
Interleukin-11/*blood | 4 | 80.0 |
Goiter/*genetics | 3 | 50.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Thyroglobulin/*genetics | 5 | 15.0 |
Cytokines/*blood | 2 | 0.0 |
Interleukin-3/blood | 2 | 50.0 |
Interleukin-8/blood | 2 | 2.0 |
Stem Cell Factor/blood | 2 | 40.0 |
Autoimmune Diseases/*immunology | 19 | 11.0 |
Epitopes/*immunology | 5 | 2.0 |
Iodide Peroxidase/genetics/*immunology | 10 | 100.0 |
Precipitin Tests | 6 | 0.0 |
Thyroid Diseases/*immunology | 14 | 46.0 |
Bone Marrow Cells/pathology | 4 | 7.0 |
*Chromosome Aberrations | 3 | 0.0 |
Leukocytes/enzymology | 2 | 1.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Proportional Hazards Models | 2 | 0.0 |
Graves' Disease/genetics | 2 | 25.0 |
Autoantigens/*genetics | 4 | 5.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Hematopoietic Cell Growth Factors/pharmacology | 5 | 6.0 |
Hematopoietic Stem Cell Transplantation | 2 | 1.0 |
Mice, Inbred DBA | 2 | 0.0 |
COS Cells | 4 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Carrier Proteins/*chemistry | 2 | 3.0 |
Iodide Peroxidase/chemistry | 2 | 100.0 |
Membrane Proteins/*chemistry | 2 | 4.0 |
Receptors, Thyrotropin/chemistry | 2 | 100.0 |
*Sequence Homology | 2 | 13.0 |
Thyroglobulin/chemistry | 2 | 100.0 |
Thyroid Gland/*chemistry | 4 | 28.0 |
Viral Proteins/*chemistry | 2 | 16.0 |
Luminescent Measurements | 2 | 2.0 |
Iodine Radioisotopes/*therapeutic use | 2 | 6.0 |
Hematologic Diseases/*blood | 2 | 20.0 |
Thrombocytosis/*blood/complications | 2 | 100.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Repressor Proteins/genetics | 2 | 1.0 |
Trans-Activators/genetics | 2 | 0.0 |
Binding, Competitive | 10 | 0.0 |
Chromatography, Affinity | 5 | 0.0 |
Chromatography, High Pressure Liquid | 7 | 0.0 |
Cloning, Molecular | 15 | 0.0 |
Insects | 3 | 1.0 |
DNA, Complementary | 5 | 0.0 |
Mammals | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Iodide Peroxidase/*biosynthesis/genetics | 3 | 100.0 |
Thyroglobulin/*biosynthesis/genetics | 2 | 66.0 |
Thyroid Gland/metabolism | 5 | 9.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Autoantibodies/*biosynthesis/blood | 2 | 33.0 |
Graves' Disease/blood/*immunology | 4 | 44.0 |
Thyroid Diseases/blood/*immunology | 2 | 66.0 |
Thyroiditis, Autoimmune/blood/*immunology | 7 | 70.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
Dialysis | 3 | 6.0 |
Drug Stability | 2 | 0.0 |
Tyrosine/metabolism | 8 | 0.0 |
HIV Infections/complications | 2 | 4.0 |
Immunodominant Epitopes/immunology | 2 | 10.0 |
*Iron-Binding Proteins | 14 | 36.0 |
Protein Denaturation | 4 | 1.0 |
Recombinant Fusion Proteins/immunology | 5 | 4.0 |
*Gene Expression Regulation | 4 | 0.0 |
Thyroglobulin/*metabolism | 6 | 31.0 |
*Megakaryocytes | 3 | 25.0 |
*Gene Transfer Techniques | 3 | 0.0 |
*Genetic Vectors | 3 | 0.0 |
Hematopoietic Stem Cells/cytology/*drug effects | 2 | 3.0 |
Japan | 2 | 0.0 |
Thrombopoietin/*biosynthesis/*genetics | 2 | 100.0 |
Thyroid Gland | 2 | 25.0 |
Autoantigens/*immunology | 12 | 7.0 |
Cross Reactions | 10 | 1.0 |
Ligands | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Graves' Disease/*enzymology/*immunology | 2 | 100.0 |
Cell Aggregation | 2 | 1.0 |
Down-Regulation | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 5 | 0.0 |
Proteins/*metabolism | 3 | 0.0 |
Antigens, CD34/*analysis | 2 | 0.0 |
Megakaryocytes/*physiology | 4 | 22.0 |
Thrombopoietin/*genetics/pharmacology/physiology | 2 | 100.0 |
CD4-Positive T-Lymphocytes/*immunology | 2 | 0.0 |
Immunization | 2 | 0.0 |
Thyroiditis, Autoimmune/immunology/*therapy | 2 | 100.0 |
Membrane Proteins/*pharmacology | 2 | 4.0 |
*Epitopes | 4 | 2.0 |
Thyroiditis, Autoimmune/*genetics | 2 | 18.0 |
Interleukin-11/metabolism | 2 | 33.0 |
Megakaryocytes/*metabolism | 2 | 6.0 |
Stem Cell Factor/metabolism | 2 | 8.0 |
Thrombocytopenia/prevention & control | 2 | 40.0 |
*Cell Cycle Proteins | 2 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Liver/metabolism | 4 | 0.0 |
Thrombopoietin/biosynthesis/*blood | 2 | 100.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Growth Substances/*pharmacology | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Blotting, Southern | 7 | 0.0 |
Iodide Peroxidase/analysis/*genetics | 2 | 100.0 |
RNA/analysis | 2 | 0.0 |
*Infant, Premature | 2 | 3.0 |
Thrombopoietin/*analysis/genetics | 2 | 100.0 |
Chromosome Mapping | 4 | 0.0 |
Goiter/genetics | 2 | 33.0 |
Haplotypes | 2 | 0.0 |
Hypothyroidism/congenital/genetics | 2 | 50.0 |
Mutation/*genetics | 2 | 0.0 |
Crystallization | 3 | 1.0 |
Thrombocytopenia/*blood/etiology | 2 | 50.0 |
DNA, Satellite/*analysis | 2 | 11.0 |
*Gene Frequency | 2 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Sampling Studies | 2 | 1.0 |
Iodide Peroxidase/deficiency/*genetics/metabolism | 2 | 100.0 |
Thyroglobulin/metabolism | 6 | 23.0 |
Thrombocytopenia/drug therapy | 2 | 50.0 |
Thyroid Gland/cytology/*enzymology | 2 | 100.0 |
Thyroid Neoplasms/*genetics/pathology | 2 | 6.0 |
Erythropoietin/blood | 2 | 3.0 |
Myelodysplastic Syndromes/*blood | 2 | 18.0 |
Protein Structure, Secondary | 2 | 0.0 |
Liver/pathology | 2 | 1.0 |
Goiter/congenital/*genetics | 2 | 50.0 |
Hematopoietic Stem Cells/*cytology | 5 | 2.0 |
*Cell Division | 2 | 1.0 |
Hepatoblastoma/*blood | 2 | 100.0 |
Liver Neoplasms/*blood | 2 | 8.0 |
Proto-Oncogene Proteins/biosynthesis | 2 | 1.0 |
DNA/biosynthesis | 2 | 0.0 |
Interleukin-3/*pharmacology | 4 | 3.0 |
*Polyploidy | 2 | 7.0 |
Iodine/metabolism | 4 | 17.0 |
Megakaryocytes/*cytology/drug effects | 2 | 16.0 |
Megakaryocytes/cytology/*drug effects/ultrastructure | 2 | 100.0 |
Membrane Glycoproteins/analysis | 2 | 0.0 |
Thrombopoietin/*metabolism/pharmacology | 3 | 50.0 |
Interleukin-3/physiology | 3 | 10.0 |
Aging/*immunology | 2 | 1.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Thrombopoietin/biosynthesis/blood/*genetics | 2 | 100.0 |
Stem Cell Factor/*pharmacology | 3 | 5.0 |
Purpura, Thrombocytopenic, Idiopathic/blood/physiopathology | 2 | 100.0 |
Thrombocytosis/*etiology | 2 | 40.0 |
*Proto-Oncogenes | 2 | 0.0 |
*Plateletpheresis | 2 | 20.0 |
Thrombopoietin/*administration & dosage | 4 | 80.0 |
Hematopoietic Stem Cells/*drug effects | 2 | 3.0 |
Macaca mulatta | 4 | 0.0 |
Antineoplastic Combined Chemotherapy Protocols/therapeutic use | 2 | 0.0 |
Antigens, CD34/immunology | 2 | 3.0 |
Bone Marrow/metabolism | 3 | 2.0 |
Clone Cells/*cytology | 2 | 50.0 |
Culture Techniques/*methods | 2 | 9.0 |
Fetal Blood/metabolism | 2 | 3.0 |
Cytokines/*physiology | 2 | 1.0 |
Carboplatin/administration & dosage | 3 | 7.0 |
Hematopoietic Stem Cells/pathology | 2 | 5.0 |
Antibodies/*immunology | 2 | 1.0 |
Genetic Vectors/*immunology | 2 | 50.0 |
Thrombocytopenia/immunology | 2 | 22.0 |
Clone Cells | 3 | 0.0 |
Immunity, Cellular | 2 | 0.0 |
Peptide Fragments/chemistry/immunology | 2 | 3.0 |
Immunosuppression | 2 | 1.0 |
Iodide Peroxidase/chemistry/*isolation & purification/metabolism | 2 | 100.0 |
Spodoptera | 2 | 0.0 |
*Genes, Immunoglobulin | 3 | 1.0 |
Immunodominant Epitopes/*immunology | 2 | 6.0 |
Liver/cytology/*metabolism | 2 | 2.0 |
Stem Cell Factor/metabolism/pharmacology | 2 | 40.0 |
Cell Membrane/enzymology | 3 | 1.0 |
Protein Kinase C/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Thrombocythemia, Hemorrhagic/blood | 2 | 28.0 |
Bone Marrow Transplantation | 2 | 0.0 |
Chimera | 3 | 1.0 |
Immunoglobulin G/biosynthesis | 3 | 1.0 |
Anemia, Aplastic/blood | 3 | 33.0 |
*Enzyme-Linked Immunosorbent Assay | 3 | 3.0 |
Immunoglobulin G/*analysis | 2 | 2.0 |
Lymph Nodes/immunology | 2 | 2.0 |
Sequence Analysis | 3 | 0.0 |
Isoenzymes/*analysis | 2 | 4.0 |
Microsomes/enzymology | 5 | 4.0 |
Autoantigens/immunology | 12 | 8.0 |
Graves' Disease/immunology | 10 | 22.0 |
RNA, Messenger/analysis/metabolism | 2 | 1.0 |
Autoimmune Diseases/immunology | 2 | 2.0 |
Prevalence | 7 | 0.0 |
Erythropoiesis/drug effects | 2 | 4.0 |
Granulocyte Colony-Stimulating Factor/*administration & dosage | 2 | 7.0 |
Whole-Body Irradiation | 2 | 2.0 |
*Bone Marrow Cells | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Thrombopoietin/*blood/genetics | 2 | 100.0 |
Transcription Factors/*genetics | 2 | 0.0 |
*Epitope Mapping | 2 | 3.0 |
Karyotyping | 3 | 0.0 |
Syndrome | 5 | 0.0 |
Chromatography, Liquid | 2 | 1.0 |
Escherichia coli/*genetics | 2 | 2.0 |
HLA-DR Antigens/analysis | 3 | 0.0 |
Immunoglobulins, Fab/*immunology | 2 | 7.0 |
Epitopes/analysis | 3 | 1.0 |
Platelet Aggregation/drug effects/physiology | 2 | 10.0 |
Bone Marrow Cells | 6 | 1.0 |
Gene Therapy | 2 | 0.0 |
Autoantigens/*isolation & purification | 2 | 33.0 |
Chromatography, Ion Exchange | 3 | 0.0 |
Iodide Peroxidase/*immunology/*isolation & purification | 2 | 100.0 |
Thyroid Gland/*enzymology/*immunology | 2 | 100.0 |
Models, Biological | 4 | 0.0 |
Autoradiography | 2 | 0.0 |
Autoantibodies/*pharmacology | 2 | 22.0 |
Cyclic AMP/biosynthesis | 2 | 1.0 |
Immunoglobulin G/*metabolism | 3 | 4.0 |
Receptors, Thyrotropin/metabolism | 2 | 50.0 |
Iodide Peroxidase/*genetics/*metabolism | 3 | 100.0 |
Immunoassay/*methods | 2 | 2.0 |
Iodine Radioisotopes/diagnostic use | 5 | 1.0 |
Cytokines/physiology | 2 | 1.0 |
Autoantibodies/genetics/*immunology | 4 | 40.0 |
Autoantibodies/blood/immunology | 2 | 10.0 |
Thyrotropin/pharmacology | 4 | 6.0 |
Models, Genetic | 2 | 0.0 |
Proto-Oncogene Proteins/analysis | 2 | 1.0 |
Thyroid Gland/*physiopathology | 3 | 11.0 |
Receptors, Thyrotropin/*genetics | 3 | 4.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Chromatography, Gel | 6 | 0.0 |
Goiter/metabolism | 2 | 20.0 |
Isotope Labeling/methods | 2 | 8.0 |
Trypsin | 2 | 1.0 |
Glycosylation | 3 | 0.0 |
Interleukin-1/*pharmacology | 2 | 0.0 |
Microscopy, Electron, Scanning | 2 | 0.0 |
Thrombocytopenia/etiology/*prevention & control | 2 | 66.0 |
Whole-Body Irradiation/*adverse effects | 2 | 33.0 |
Exons | 4 | 0.0 |
DNA/genetics | 8 | 0.0 |
Hypothyroidism/*congenital/*genetics | 2 | 50.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Thyroxine/metabolism | 6 | 25.0 |
Triiodothyronine/metabolism | 5 | 14.0 |
Thyroid Neoplasms/*enzymology/genetics | 2 | 66.0 |
Lod Score | 2 | 0.0 |
Recombinant Proteins/pharmacology/therapeutic use | 2 | 5.0 |
Autoantibodies/immunology | 9 | 8.0 |
Mice, Mutant Strains | 3 | 0.0 |
Stromal Cells/physiology | 2 | 3.0 |
DNA Fingerprinting/methods | 2 | 3.0 |
*Genetics, Population | 2 | 0.0 |
*Tandem Repeat Sequences | 3 | 2.0 |
Italy | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Carcinoma, Papillary/enzymology | 3 | 75.0 |
Histocytochemistry | 2 | 0.0 |
Tumor Markers, Biological/analysis | 2 | 0.0 |
*Autoantigens | 2 | 5.0 |
Iodide Peroxidase/genetics/immunology | 3 | 100.0 |
Autoantibodies/*genetics | 4 | 26.0 |
*Gene Library | 2 | 3.0 |
Autoantibodies/blood/*immunology | 3 | 8.0 |
Peptide Fragments/immunology | 3 | 1.0 |
Adenocarcinoma, Follicular/diagnosis | 2 | 66.0 |
Antigens, CD26/*analysis | 2 | 40.0 |
Carcinoma, Papillary/diagnosis | 2 | 66.0 |
Thyroid Neoplasms/*diagnosis | 3 | 25.0 |
Thyroglobulin/analysis | 4 | 17.0 |
Antigens, CD/analysis | 2 | 0.0 |
Epitopes/*analysis | 4 | 2.0 |
Rats, Wistar | 2 | 0.0 |
Thyroglobulin/*pharmacology | 2 | 40.0 |
Iodide Peroxidase/antagonists & inhibitors/*immunology | 4 | 100.0 |
Lactoperoxidase/immunology | 2 | 100.0 |
Peroxidase/immunology | 4 | 11.0 |
Epitopes | 7 | 0.0 |
Immunoglobulin G/classification/immunology | 2 | 28.0 |
Puerperal Disorders/*immunology | 2 | 33.0 |
Thyroiditis/*immunology | 3 | 33.0 |
*Thyroid Function Tests | 3 | 23.0 |
Hybridomas/immunology | 2 | 1.0 |
Thyroglobulin/biosynthesis/*genetics | 3 | 37.0 |
Antibodies, Monoclonal/genetics/immunology | 2 | 18.0 |
Macromolecular Substances | 3 | 0.0 |
Hypothyroidism/immunology | 2 | 50.0 |
Iodide Peroxidase/antagonists & inhibitors | 2 | 66.0 |
Immunoglobulins, Thyroid-Stimulating | 2 | 8.0 |
Interferon-gamma, Recombinant/*pharmacology | 2 | 1.0 |
Iodide Peroxidase/analysis/*metabolism | 2 | 100.0 |
Thyroid Gland/drug effects/*metabolism | 2 | 18.0 |
Thyrotropin/*pharmacology | 3 | 10.0 |
*Antibody Specificity | 2 | 2.0 |
Antigens/immunology | 2 | 1.0 |
Immunoglobulins, Heavy-Chain/genetics/*immunology | 2 | 28.0 |
Immunoglobulins, Light-Chain/genetics/*immunology | 2 | 100.0 |
Herpesvirus 4, Human/*genetics | 2 | 2.0 |
Mice/*genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
Hypothyroidism/etiology | 2 | 33.0 |
RNA, Messenger/*analysis/genetics | 2 | 4.0 |
Epitopes/*genetics/immunology | 3 | 21.0 |
Microsomes/enzymology/*immunology | 3 | 100.0 |
Cloning, Molecular/*methods | 2 | 3.0 |
Genomic Library | 2 | 0.0 |
Graves' Disease/*metabolism | 3 | 27.0 |
Iodide Peroxidase/*immunology/metabolism | 3 | 100.0 |
Autoantibodies/*biosynthesis | 5 | 8.0 |
Bacteriophage lambda/*genetics | 2 | 25.0 |
Moths | 2 | 4.0 |
Iodide Peroxidase/*genetics/immunology | 3 | 100.0 |
Receptors, Thyrotropin/*genetics/immunology | 2 | 40.0 |
Thyroglobulin/*antagonists & inhibitors | 2 | 66.0 |
Monocytes/immunology | 2 | 0.0 |
Immunoglobulin G/immunology | 3 | 0.0 |
DNA Probes | 7 | 0.0 |
Gene Expression/*drug effects | 2 | 0.0 |
Graves' Disease/metabolism | 2 | 10.0 |
Random Allocation | 2 | 0.0 |
Microsomes/*immunology | 7 | 46.0 |
Microvilli/enzymology | 2 | 9.0 |
Catalysis | 4 | 0.0 |
Iodide Peroxidase/genetics/physiology | 2 | 100.0 |
Protein Conformation/drug effects | 2 | 3.0 |
Radioimmunoassay/methods | 2 | 1.0 |
Microsomes/immunology | 6 | 26.0 |
Goiter/*congenital/genetics | 2 | 100.0 |
Thrombocytosis/*blood/etiology | 2 | 100.0 |
Leukocytes, Mononuclear/*immunology | 2 | 1.0 |
Lactoperoxidase/metabolism | 2 | 28.0 |
Peroxidase/*metabolism | 2 | 3.0 |
*Autoimmunity | 2 | 3.0 |
Lymphocytes/immunology | 2 | 0.0 |
Iodide Peroxidase/*chemistry/immunology | 2 | 100.0 |
Cytoplasm/enzymology | 2 | 2.0 |
Thrombopoiesis | 2 | 100.0 |
Adenoma/enzymology | 2 | 28.0 |
HLA-DR Antigens/immunology | 2 | 0.0 |
Actins/genetics | 2 | 1.0 |
Staining and Labeling | 3 | 0.0 |
Methimazole/*pharmacology | 2 | 40.0 |
Propylthiouracil/*pharmacology | 2 | 50.0 |
Plasmids | 2 | 0.0 |
Thyroglobulin/genetics/*immunology | 2 | 66.0 |
Thyroid Neoplasms/*metabolism/pathology | 2 | 4.0 |
Antigen-Antibody Reactions | 4 | 1.0 |
Lactoperoxidase/*metabolism | 2 | 50.0 |
Thyroid Gland/enzymology/*immunology | 3 | 100.0 |
Mice, Inbred Strains | 2 | 0.0 |
Graves' Disease/enzymology | 4 | 100.0 |
Peroxidases/*analysis | 2 | 18.0 |
Thyroid Gland/*enzymology/pathology | 2 | 66.0 |
Antigens, Surface/immunology | 2 | 1.0 |
Protein Disulfide-Isomerase | 2 | 10.0 |
Immunoelectrophoresis | 2 | 0.0 |
Dose-Response Relationship, Immunologic | 3 | 0.0 |
Peroxidase/*immunology | 2 | 6.0 |
*Iodide Peroxidase | 5 | 71.0 |
Peroxidase | 5 | 62.0 |
Thyroid Gland/*enzymology/immunology | 3 | 100.0 |
Hypothyroidism/enzymology/genetics | 2 | 100.0 |
Iodide Peroxidase/analysis/*immunology | 2 | 100.0 |
Temperature | 2 | 0.0 |
Methods | 2 | 0.0 |
Monoiodotyrosine/*metabolism | 2 | 100.0 |
Autoantigens/genetics/*immunology | 2 | 20.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Antibodies/*analysis | 4 | 3.0 |
Thyroiditis, Autoimmune/*enzymology/immunology | 3 | 100.0 |
Antibodies, Monoclonal/diagnostic use | 2 | 0.0 |
Peroxidases/*immunology | 2 | 40.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Immunochemistry | 4 | 1.0 |
Chemistry | 3 | 1.0 |
Peroxidases/*metabolism | 3 | 10.0 |
Immunodominant Epitopes/chemistry/*immunology | 2 | 33.0 |
